Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by CHHABRA, R. S.
Right arrow Articles by HETJMANCIK, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by CHHABRA, R. S.
Right arrow Articles by HETJMANCIK, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1990 Oxford University Press

other

Dermal Toxicity and Carcinogenicity of 4-Vinyl-1 -cyclohexene Diepoxide in Fischer Rats and B6C3F1 Mice

R. S. CHHABRA, JAMES HUFF, J. HASEMAN, M. P. JOKJNEN and M. HETJMANCIK*

National Institute of Environmental Health Sciences Research Triangle Park, North Carolina 27709 *Ballelle Memorial Institute Columbus, Ohio 43201

Received July 24, 1989; accepted December 28, 1989

Dermal Toxicity and Carcinogenicity of 4-Vinyl-1-cyclohexene Diepoxide in Fischer Rats and B6C3F1 Mice. CHHABRA, R. S., HUFF, J., HASEMAN, J., JOKJNEN, M. P., AND HETJMANCIK, M. (1990). Fundam. Appl. Toxicol 14, 752–763. 4-Vinyl-l-cyclohexene diepoxide (VCHD) is used as a chemical intermediate and as a reactive diluent for diepoxides and epoxy resins. Studies were conducted by administering VCHD in acetone by dermal application, 5 days per week for 105 weeks, to groups of 60 rats of each sex at 0, 15, or 30 mg/animal. Groups of 60 mice of each sex were administered 0, 2.5, 5, or 10 mg/animal on the same schedule for up to 103 weeks. Ten animals from each group were humanely killed, necropsied, and examined histopathologically during Month 15. At the 15-month evaluation, 2 of 10 male rats that received 30 mg had a squamous cell carcinoma of the skin at or adjacent to the site of application. Squamous cell papillomas and carcinomas were seen in all mice that received 5 or 10 mg. Two of nine female mice given 10 mg had granulosa cell tumors of the ovary, and one of nine female mice given 10 mg had an ovarian papillary cystadenoma. In the 2-year studies, body weight and survival were lower in high-dose rats and mid- and high-dose mice than in vehicle controls. All high-dose male mice died by Week 83; remaining high-dose female mice were killed during Week 84 for humane reasons. Squamous cell papillomas of the skin in dermally exposed male rats and squamous cell carcinomas and basal cell adenomas or carcinomas of the skin in exposed male and female rats were increased. The incidence of squamous cell carcinomas of the skin was increased in male and female mice at all dose levels. Mid- and high-dose female mice had an increased incidence of benign or malignant granulosa cell tumors and of benign mixed tumors of the Ovary.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.